Mutations in RNU7-1 Weaken Secondary RNA Structure, Induce MCP-1 and CXCL10 in CSF, and Result in Aicardi-Goutières Syndrome with Severe End-Organ Involvement.

MLA

Naesens, Leslie, et al. “Mutations in RNU7-1 Weaken Secondary RNA Structure, Induce MCP-1 and CXCL10 in CSF, and Result in Aicardi-Goutières Syndrome with Severe End-Organ Involvement.” Journal of Clinical Immunology, vol. 42, no. 5, July 2022, pp. 962–74. EBSCOhost, https://doi.org/10.1007/s10875-022-01209-5.

APA

Naesens, L., Nemegeer, J., Roelens, F., Vallaeys, L., Meuwissen, M., Janssens, K., Verloo, P., Ogunjimi, B., Hemelsoet, D., Program for Undiagnosed Rare Diseases (UD-PrOZA), Callens, S., Dermaut, B., Terryn, W., Schuermans, N., Poppe, B., Hoste, L., Roels, L., De Bruyne, M., De Baere, E., & Van Dorpe, J. (2022). Mutations in RNU7-1 Weaken Secondary RNA Structure, Induce MCP-1 and CXCL10 in CSF, and Result in Aicardi-Goutières Syndrome with Severe End-Organ Involvement. Journal of Clinical Immunology, 42(5), 962–974. https://doi.org/10.1007/s10875-022-01209-5

Chicago

Naesens, Leslie, Josephine Nemegeer, Filip Roelens, Lore Vallaeys, Marije Meuwissen, Katrien Janssens, Patrick Verloo, et al. 2022. “Mutations in RNU7-1 Weaken Secondary RNA Structure, Induce MCP-1 and CXCL10 in CSF, and Result in Aicardi-Goutières Syndrome with Severe End-Organ Involvement.” Journal of Clinical Immunology 42 (5): 962–74. doi:10.1007/s10875-022-01209-5.